4.6 Article

Successful Treatment with Infliximab for Inflammatory Colitis in a Patient with X-linked Anhidrotic Ectodermal Dysplasia with Immunodeficiency

Related references

Note: Only part of the references are listed.
Article Genetics & Heredity

NEMO mutation as a cause of familial occurrence of Behcet's disease in female patients

H. Takada et al.

CLINICAL GENETICS (2010)

Article Gastroenterology & Hepatology

Inflammatory Bowel Disease in CGD Reproduces the Clinicopathological Features of Crohn's Disease

Daniel J. B. Marks et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)

Letter Gastroenterology & Hepatology

Hepatosplenic T Cell Lymphoma Associated with Infliximab Use in Young Patients Treated for Inflammatory Bowel Disease: Update

Ann Corken Mackey et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2009)

Article Multidisciplinary Sciences

Epithelial NEMO links innate immunity to chronic intestinal inflammation

Arianna Nenci et al.

NATURE (2007)

Article Gastroenterology & Hepatology

Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease

Ann Corken Mackey et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2007)

Article Immunology

X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production

Orchidee Filipe-Santos et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2006)

Letter Gastroenterology & Hepatology

Crohn's disease in common variable immunodeficiency: Treatment with antitumor necrosis factor alpha

Pilar Nos et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)

Article Gastroenterology & Hepatology

Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease

JMH Van Den Brande et al.

GASTROENTEROLOGY (2003)